MacroGenics, Inc. (MGNX) Social Stream
MACROGENICS INC (MGNX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MACROGENICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 9 | $50 | $17 | $37.5 | $4.86 | 671.6% |
| 2021-11-17 | 8 | $50 | $30 | $40.428 | $4.86 | 731.85% |
| 2022-02-07 | 9 | $50 | $30 | $40.375 | $4.86 | 730.76% |
| 2022-02-11 | 10 | $50 | $30 | $39.333 | $4.86 | 709.32% |
| 2022-02-24 | 10 | $50 | $23 | $35.444 | $4.86 | 629.3% |
| 2022-02-28 | 10 | $50 | $21 | $33.333 | $4.86 | 585.86% |
| 2022-05-03 | 10 | $50 | $21 | $32.777 | $4.86 | 574.42% |
| 2022-05-04 | 10 | $50 | $15 | $31.222 | $4.86 | 542.43% |
| 2022-07-18 | 10 | $50 | $4 | $22.333 | $4.86 | 359.53% |
| 2022-08-09 | 10 | $50 | $4 | $20.9 | $4.86 | 330.04% |
| 2022-08-23 | 11 | $50 | $4 | $19.9 | $4.86 | 309.47% |
| 2022-08-29 | 11 | $50 | $4 | $19.4 | $4.86 | 299.18% |
| 2022-09-12 | 11 | $50 | $4 | $16.9 | $4.86 | 247.74% |
| 2022-11-03 | 10 | $30 | $4 | $13.555 | $4.86 | 178.91% |
| 2022-11-07 | 10 | $30 | $4 | $13.666 | $4.86 | 181.19% |
| 2022-11-14 | 10 | $30 | $5 | $15 | $4.86 | 208.64% |
| 2022-11-23 | 9 | $20 | $5 | $12 | $4.86 | 146.91% |
| 2023-03-09 | 10 | $20 | $5 | $12.222 | $4.86 | 151.48% |
| 2023-03-15 | 10 | $20 | $5 | $12 | $4.86 | 146.91% |
| 2023-03-20 | 11 | $20 | $5 | $12.222 | $4.86 | 151.48% |
| 2023-05-09 | 11 | $20 | $5 | $12.3 | $4.86 | 153.09% |
The Trend in the Analyst Price Target
Over the past 18 months, MGNX's average price target has gone down $25.2.
Over the past 42 weeks, MGNX's average upside potential has been 224.09%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-12 | 11 | 50 | 4 | 16.900 | 3.89 | 334.45% |
| 2022-11-07 | 10 | 30 | 4 | 13.666 | 6.42 | 112.87% |
| 2022-11-14 | 10 | 20 | 5 | 13.125 | 6.98 | 88.04% |
| 2022-11-14 | 10 | 30 | 5 | 15.000 | 6.98 | 114.9% |
| 2023-03-20 | 11 | 20 | 5 | 12.222 | 6.69 | 82.69% |
MGNX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.55 | 8 | 0 | 3 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 52 weeks, MGNX's average broker recommendation rating worsened by 0.35.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, MACROGENICS INC's upside potential (average analyst target price relative to current price) is higher than 2406.35% of them.
- MGNX has a lower variance in analysts' estimates than -2278.45% of all US stocks.
- In terms of how MACROGENICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 2007.01% of that group.
- In terms of how MACROGENICS INC fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 823.46% of that group.
In the Pharmaceutical Products industry, CYRX, INFI, and INSM are the three stocks most similar to MACROGENICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding MGNX using the data that counts. Try POWR Ratings for free.